IP Library Granted Patent US 7,563,600
Granted Patent B2
US 7,563,600 · App. 10/243,367 · Granted Jul 21, 2009

Microarray synthesis and assembly of gene-length polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,563,600
App. No.
10/243,367
Granted
Jul 21, 2009
Kind
B2
Abstract

There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.

Claims (8)

1. A composition for the manufacture of a polynucleotide sequence comprising:

a first oligonucleotide comprising at its 5′ end a sequence region of about 10 to about 50 bases that is the same as a sequence region at the 3′ end of another oligonucleotide in the composition;

a second oligonucleotide comprising at its 3′ end a sequence region of about 10 to about 50 bases that is the same as a sequence region at the 5′ end of another oligonucleotide in the composition; and

a plurality of oligonucleotides wherein each oligonucleotide of the plurality comprises a first sequence region of about 10 to about 50 bases at its 5′ end that is the same as a sequence region at the 3′ end of another oligonucleotide in the composition and a second distinct sequence region of about 10 to about 50 bases at its 3′ end that is the same as a sequence region at the 5′ end of a different oligonucleotide in the composition;

wherein the oligonucleotides of the composition are attached to a solid or porous surface and wherein the oligonucleotides of the composition together comprise the polynucleotide sequence.

2. The composition of claim 1 , further comprising (i) a primer that binds specifically to a sequence region at the 3′ end of the first oligonucleotide, and (ii) a polymerase.

3. The composition of claim 1 , wherein the solid or porous surface is in the form of a microarray device.

4. The composition of claim 3 , wherein the microarray device is a semiconductor device having a plurality of electrodes for synthesizing oligonucleotides in situ using electrochemical means to couple and decouple nucleotide bases.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2011
From: COMBIMATRIX CORPORATION
To: GEN9, INC.
Reel/Frame 025669/0462 →
SECURITY AGREEMENT Recorded Aug 28, 2008
From: COMBIMATRIX CORPORATION; COMBIMATRIX MOLECULAR DIAGNOSTICS, INC.
To: YA GLOBAL INVESTMENTS, L.P.
Reel/Frame 021450/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2002
From: OLEINIKOV, ANDREW V.
To: COMBIMATRIX CORPORATION
Reel/Frame 013307/0663 →